Clinical Trials Directory

Trials / Completed

CompletedNCT03208894

Role of Salbutamol and Furosemide in TTN

Role of Salbutamol and Furosemide in Transient Tachypnea of Newborn

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Armed Forces Hospital, Pakistan · Academic / Other
Sex
All
Age
1 Hour – 7 Days
Healthy volunteers
Not accepted

Summary

to see the effects of slabutamol and IV furosemide in the treatment of transient tachypnea of newborn

Conditions

Interventions

TypeNameDescription
DRUGFurosemide Injectionefficacy of salbutamol and furosemide in TTN

Timeline

Start date
2016-11-01
Primary completion
2017-05-30
Completion
2017-06-30
First posted
2017-07-06
Last updated
2017-07-06

Locations

2 sites across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT03208894. Inclusion in this directory is not an endorsement.

Role of Salbutamol and Furosemide in TTN (NCT03208894) · Clinical Trials Directory